AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Hi, this is Colum Murphy, writing from the coastal town of Boao, where China is stepping up its charm offensive and pitching ...

They include Rajesh Subramaniam of FedEx, Bill Winters of Standard Chartered, Paul Hudson of Sanofi, Pascal Soriot of ...

Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, ...

Chief Executive Officer Pascal Soriot has frequently talked up the scientific promise of China. Friday’s announcement came as he met Beijing’s Mayor Yin Yong, who according to Chinese media ...

China is ready for “unexpected shocks”, premier Li Qiang said China told a gathering of foreign CEOs including Tim Cook of Apple (AAPL) and ...

Investing.com -- AstraZeneca (NASDAQ: AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...

Chief Executive Pascal Soriot was in Beijing and met with the city's mayor to reveal the investment, along with two licensing deals with Chinese companies, and a joint venture with a third Chinese ...